AstraZeneca inhaler lags GSK drug in lung disease trial

A new AstraZeneca inhaler for chronic lung disease has proved worse than a rival GlaxoSmithKline product in a clinical trial, a result AstraZeneca said was inconsistent with earlier findings.


from Reuters: Health News https://ift.tt/2wlCzaz
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Nevada Gov. Steve Sisolak Tests Positive For Coronavirus

Nevada Gov. Steve Sisolak Tests Positive For Coronavirus "With my case, I want to underscore the importance of Nevadans to stay at hom...